Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-09 Sale | 2022-02-11 6:10 pm | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 397 | $36.3 | $14,411 | 65,848 (Direct) | View |
| 2021-03-04 Sale | 2021-03-05 8:56 pm | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $105.04 | $3,734,075 | 118,295 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-09 Option Award | 2022-02-11 6:10 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 62,400 | $0 | 65,848 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 8:56 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $51.28 | 118,295 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 8:56 pm | N/A 2030-03-01 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $0 | 118,295 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:55 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 21,148 | $0 | 21,148 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-02 7:11 pm | N/A 2030-03-01 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |